0001104659-24-039164.txt : 20240326
0001104659-24-039164.hdr.sgml : 20240326
20240326190136
ACCESSION NUMBER: 0001104659-24-039164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240326
DATE AS OF CHANGE: 20240326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly James Patrick
CENTRAL INDEX KEY: 0001506314
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26770
FILM NUMBER: 24785261
MAIL ADDRESS:
STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC.
STREET 2: 9715 KEY WEST AVENUE
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NOVAVAX INC
CENTRAL INDEX KEY: 0001000694
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 222816046
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-268-2000
MAIL ADDRESS:
STREET 1: 700 QUINCE ORCHARD ROAD
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
tm249879-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-01
0
0001000694
NOVAVAX INC
NVAX
0001506314
Kelly James Patrick
C/O NOVAVAX, INC.
700 QUINCE ORCHARD ROAD
GAITHERSBURG
MD
20878
0
1
0
0
EVP, CFO & Treasurer
0
Restricted Stock Units
2024-03-01
4
A
0
176000
0.00
A
Common Stock
176000
176000
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date.
/s/ Mark J. Casey, Attorney-in-Fact
2024-03-26